Saturday, June 25, 2016 12:07:22 AM
So Braun is a positive. Do you see any problem with the NHS approval? Several board members feel that since Braun is such an established component of the NHS, with hundreds of items already on the Drug Tariff, that approval is a 99% given. The NHS is running deficits and needs to cut costs. RecoveryRx can significantly reduce drug expenses and hospital stays. Once RecoveryRx is approved ActiPatch, which is the same product in a different box, if not initially added with RecoveryRx to the NHS Tariff should follow shortly.
What do you see in annual sales for a country of 65 million people when the National Health Service is covering the cost of the RecoveryRx/ActiPatch?
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM